[go: up one dir, main page]

BR0314056A - Métodos de medição da taxa de dissolução de um analisado em uma composição lìquida não-aquosa - Google Patents

Métodos de medição da taxa de dissolução de um analisado em uma composição lìquida não-aquosa

Info

Publication number
BR0314056A
BR0314056A BR0314056-3A BR0314056A BR0314056A BR 0314056 A BR0314056 A BR 0314056A BR 0314056 A BR0314056 A BR 0314056A BR 0314056 A BR0314056 A BR 0314056A
Authority
BR
Brazil
Prior art keywords
liquid composition
analyte
methods
dissolution rate
aqueous liquid
Prior art date
Application number
BR0314056-3A
Other languages
English (en)
Inventor
Randal Lee Schapaugh
Jamie K North
Edward L Ciolkowski
Leslie C Eaton
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of BR0314056A publication Critical patent/BR0314056A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"MéTODOS DE MEDIçãO DA TAXA DE DISSOLUçãO DE UM ANALISADO EM UMA COMPOSIçãO LìQUIDA NãO-AQUOSA". A presente invenção proporciona um método de caracterização da transferência de um analisado de uma composição líquida não-aquosa para um meio aquoso, e particularmente, um método in vitro para medir a dissolução de um fármaco a partir de uma forma de dosagem de liberação prolongada.
BR0314056-3A 2002-09-12 2003-09-10 Métodos de medição da taxa de dissolução de um analisado em uma composição lìquida não-aquosa BR0314056A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41014702P 2002-09-12 2002-09-12
PCT/US2003/025853 WO2004024121A2 (en) 2002-09-12 2003-09-10 Methods of measuring the dissolution rates of an analyte in a non-aqueous liquid composition

Publications (1)

Publication Number Publication Date
BR0314056A true BR0314056A (pt) 2005-07-05

Family

ID=31994073

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314056-3A BR0314056A (pt) 2002-09-12 2003-09-10 Métodos de medição da taxa de dissolução de um analisado em uma composição lìquida não-aquosa

Country Status (8)

Country Link
US (1) US20040115822A1 (pt)
EP (1) EP1540337A2 (pt)
JP (1) JP2006503269A (pt)
AU (1) AU2003265484A1 (pt)
BR (1) BR0314056A (pt)
CA (1) CA2495521A1 (pt)
MX (1) MXPA05002761A (pt)
WO (1) WO2004024121A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7024955B2 (en) * 2003-03-01 2006-04-11 Symyx Technologies, Inc. Methods and systems for dissolution testing
EA200901641A1 (ru) * 2007-05-29 2010-04-30 Фарма Дайэгностикс Нв Способ определения in vitro предсказанной in vivo характеристики adme или токсикологического свойства потенциального соединения и набор для его осуществления
CA2696227A1 (en) * 2007-10-17 2009-04-23 Transpharma Medical Ltd. Dissolution rate verification
US20090155920A1 (en) * 2007-11-12 2009-06-18 Symyx Technologies, Inc. High throughput dissolution and precipitation apparatus and method
DE102007058718A1 (de) * 2007-12-06 2009-06-10 Erweka Gmbh Vorrichtung und Verfahren zur automatischen Freisetzung und Messung von Wirkstoffen aus einer Arzneizubereitung
US8613214B2 (en) * 2008-01-09 2013-12-24 Orono Spectral Solutions, Inc. Apparatus and method for determining analyte content in a fluid
US8393198B2 (en) * 2008-01-09 2013-03-12 OronoSpectral Solutions, Inc. Apparatus and method for determining analyte content in a fluid
CN103728386B (zh) * 2013-12-27 2016-04-06 上海医药集团青岛国风药业股份有限公司 一种利用液相法测定多糖铁复合物溶出度的方法
CN104297372B (zh) * 2014-10-08 2016-03-30 中国农业科学院农业质量标准与检测技术研究所 一种人工模拟的猪胃和小肠消化液及其制备方法与应用
NZ735694A (en) * 2015-02-26 2023-05-26 Dsg Tech Holdings Limited Disposable absorbent core and disposable absorbent assembly including same, and method of making same
CN105158188A (zh) * 2015-07-06 2015-12-16 长春中医药大学 阿尼西坦缓释片的释药检测方法
GB201809627D0 (en) * 2018-06-12 2018-07-25 Biorelevant Com Ltd Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3791221A (en) * 1972-04-07 1974-02-12 Warner Lambert Co Dissolution testing device
US3791222A (en) * 1972-04-07 1974-02-12 Warner Lambert Co Dissolution testing device
US4335438A (en) * 1980-04-17 1982-06-15 Smolen Victor F Method and apparatus for automatic dissolution testing of products
US5459256A (en) * 1987-04-17 1995-10-17 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Lipophilic, aminohydrolase-activated prodrugs
CH680472A5 (pt) * 1989-12-18 1992-08-31 Sotax Ag
ATE202109T1 (de) * 1993-03-12 2001-06-15 Upjohn Co Kristallines ceftiofur (freie säure)
US5412979A (en) * 1993-05-03 1995-05-09 Temple University - Of The Commonwealth System Of Higher Education Method and apparatus for dissolution testing of a dosage form
US6060024A (en) * 1993-07-14 2000-05-09 Zymark Corporation Automatic dissolution testing system
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
DE29519713U1 (de) * 1995-12-12 1996-02-01 Erweka GmbH, 63150 Heusenstamm Dissolutionstestgerät
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
CA2358575A1 (en) * 2001-09-26 2003-03-26 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health Low speed precision stirring/mixing device

Also Published As

Publication number Publication date
WO2004024121A2 (en) 2004-03-25
EP1540337A2 (en) 2005-06-15
MXPA05002761A (es) 2005-06-03
AU2003265484A1 (en) 2004-04-30
US20040115822A1 (en) 2004-06-17
WO2004024121A3 (en) 2004-07-08
JP2006503269A (ja) 2006-01-26
CA2495521A1 (en) 2004-03-25
AU2003265484A8 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
RS51213B (sr) Farmaceutski vaginalni gel koji sadrži tenofovir
IL190951A0 (en) Method of acting upon organism by targeted delivery of biologicaly active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
EP1972251A4 (en) CAPSULE CONTAINER AND METHOD OF ADMINISTRATION THEREWITH
EP1730163A4 (en) Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid
BR0314056A (pt) Métodos de medição da taxa de dissolução de um analisado em uma composição lìquida não-aquosa
CL2008003910A1 (es) Formulacion liquida, estable, conteniendo anticuerpo que comprende arginina y metionina; procedimiento para inhibir la deamidacion de moleculas de un anticuerpo que comprende agregar arginina a la formulacion liquida.
MA28337A1 (fr) Derives de l'acide 7-phenylamino-4-quinolone-3-carboxylique, methodes pour leur production et leur utilisation en tant que medicaments
BRPI0812770A2 (pt) Método in vitro para identificar uma pluralidade de moléculas antigênicas transportadas por eritrócitos de um indivíduo, e/ou identificar uma pluralidade de anticorpos contra moléculas antigênicas transportadas por eritrócitos, conjunto de reagentes para implementar o método de detecção .
BRPI0620229A8 (pt) formulação
BRPI0413363A (pt) formas de dosagem fornecendo liberação controlada de inibidores de proteìna de transferência de ésteres de colesterila e liberação imediata de inibidores de hmg-coa redutase
BRPI0416986A (pt) preparação farmacêutica compreendendo um anticorpo contra o receptor de egf
BRPI0719849A2 (pt) Método de imunização contra os quatro sorotipos da dengue
DK1598333T3 (da) Fremgangsmåde til fremstilling af (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutan og syreadditionssalte heraf samt anvendelse til syntese af ivabradin og syreadditionssalte heraf med farmaceutisk acceptable syrer
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
BR112014031934A8 (pt) Método com base em euglobulina para determinar a atividade biológica de defibrotide
BRPI0815460A2 (pt) kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
SG162766A1 (en) Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors
EA201070194A1 (ru) Стабильная жидкая фармацевтическая композиция на основе тразодона
CY1107158T1 (el) Νεα παραγωγα της ισοκινολινης, η μεθοδος παρασκευης τους και η χρηση τους για τη θεραπεια των διαταραχων του μελατονινεργικου συστηματος
EA200801875A1 (ru) Антагонист cd 80
BR0314804A (pt) Forma de dosagem de liberação modificada
ITFI20050041A1 (it) Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
EA201000585A1 (ru) Многочастичная матричная система, содержащая галантамин

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.